StemoniX Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

StemoniX General Information

Description

Developer of a human-induced cardiac screening platform designed to improve and accelerate the process of neurotoxicity research and drug screening. The company's platform creates new cell-based disease models, and operationalizes custom human induced pluripotent stem cells (iPSC) disease models at a large scale for high-throughput screening, enabling scientists to conduct research with improved outcomes in a simplified workflow economically.

Contact Information

Website
www.stemonix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 13300 67th Avenue North
  • Maple Grove, MN 55311
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
AxoSim
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 13300 67th Avenue North
  • Maple Grove, MN 55311
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemoniX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. Merger/Acquisition 24-Oct-2023 Completed Generating Revenue
17. Later Stage VC (Series B) 01-Dec-2022 Completed Generating Revenue
16. Later Stage VC 01-Jun-2021 Completed Generating Revenue
15. Merger/Acquisition 30-Mar-2021 Completed Generating Revenue
14. Later Stage VC 01-Jan-2021 Completed Generating Revenue
13. Debt - PPP 10-Apr-2020 Completed Generating Revenue
12. Later Stage VC (Series B) 23-Oct-2019 Completed Generating Revenue
11. Later Stage VC 11-Oct-2019 Completed Generating Revenue
10. Early Stage VC 06-Sep-2018 $4.94M $13.3M Completed Generating Revenue
9. Early Stage VC (Series A) 10-Mar-2017 $2.41M $8.41M Completed Generating Revenue
To view StemoniX’s complete valuation and funding history, request access »

StemoniX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a human-induced cardiac screening platform designed to improve and accelerate the process of neurotoxicity
Biotechnology
Maple Grove, MN
14 As of 2022

Cambridge, United Kingdom
 

Dublin, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StemoniX Competitors (36)

One of StemoniX’s 36 competitors is DefiniGEN, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom
Nanofiber Solutions Venture Capital-Backed Dublin, OH
Hesperos Venture Capital-Backed Orlando, FL
Sernova Corporation London, Canada
Cellaïon Venture Capital-Backed Mont-Saint-Guibert, Belgium
You’re viewing 5 of 36 competitors. Get the full list »

StemoniX Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

StemoniX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020216980-A1 Method of using human spheroids for drug discovery Inactive 02-Feb-2019
JP-2023090807-A Method of using human spheroids for drug discovery Pending 02-Feb-2019
AU-2024200581-A1 Method of using human spheroids for drug discovery Pending 02-Feb-2019
US-20190085296-A1 Method of expansion of human pancreas progenitor cells from stem cells using feeder-conditioned media Inactive 20-Sep-2017
EP-3679124-A1 Efficient differentiation of human stem cells to definitive endoderm Inactive 07-Sep-2017 C12N5/0678
To view StemoniX’s complete patent history, request access »

StemoniX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StemoniX Former Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
701 Fund Angel Group Minority
Alumni Ventures Venture Capital Minority
Brightstone Venture Capital Venture Capital Minority
CONNECT (Accelerator) Accelerator/Incubator
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

StemoniX Investments (1)

StemoniX’s most recent deal was a Joint Venture with Joint Venture (StemoniX and Atomwise). The deal was made on 03-Dec-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (StemoniX and Atomwise) 03-Dec-2019 Joint Venture Drug Discovery
To view StemoniX’s complete investments history, request access »

Ready to get started?

Request a free trial

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
StemoniX (MicroBrain Technology) Maple Grove, MN

StemoniX FAQs

  • When was StemoniX founded?

    StemoniX was founded in 2014.

  • Where is StemoniX headquartered?

    StemoniX is headquartered in Maple Grove, MN.

  • What is the size of StemoniX?

    StemoniX has 14 total employees.

  • What industry is StemoniX in?

    StemoniX’s primary industry is Biotechnology.

  • Is StemoniX a private or public company?

    StemoniX is a Private company.

  • What is StemoniX’s current revenue?

    The current revenue for StemoniX is .

  • How much funding has StemoniX raised over time?

    StemoniX has raised $24.1M.

  • Who are StemoniX’s investors?

    701 Fund, Alumni Ventures, Brightstone Venture Capital, CONNECT (Accelerator), and Catalytic Impact Foundation are 5 of 25 investors who have invested in StemoniX.

  • Who are StemoniX’s competitors?

    DefiniGEN, Nanofiber Solutions, Hesperos, Sernova, and Cellaïon are some of the 36 competitors of StemoniX.

  • When was StemoniX acquired?

    StemoniX was acquired on 24-Oct-2023.

  • Who acquired StemoniX?

    StemoniX was acquired by AxoSim.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »